Japan Shoulder Replacement Market Outlook to 2033 - Partial Shoulder Replacement, Shoulder Resurfacing and Others
Summary
GlobalData’s “Japan Shoulder Replacement Market Outlook to 2033” is a comprehensive databook report, covering key market data on the Japan Shoulder Replacement market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Partial Shoulder Replacement, Shoulder Resurfacing and Others
The Japan Shoulder Replacement Market report provides key information and data on -
Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
2023 company share and distribution share data for Shoulder Replacement Market.
Global corporate-level profiles of key companies operating within the Japan Shoulder Replacement Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.
Scope
Japan Shoulder Replacement is segmented as follows -
3.3 Shoulder Replacement Market, Japan, Average Price ($), 2018-2033
3.4 Shoulder Replacement Market, Japan, Distribution Share by Revenue ($m), 2023
3.5 Shoulder Replacement Market, Japan, Company Share by Revenue ($m), 2023
4 Overview of Key Companies in Japan, Shoulder Replacement Market
4.1 DePuy Synthes Inc
4.1.1 Company Overview
4.2 Stryker Corp
4.2.1 Company Overview
4.3 ZimVie Inc
4.3.1 Company Overview
4.4 Exactech Inc
4.4.1 Company Overview
4.5 Limacorporate SpA
4.5.1 Company Overview
4.6 Mathys AG Bettlach
4.6.1 Company Overview
4.7 Smith & Nephew Plc
4.7.1 Company Overview
4.8 Arthrex Inc
4.8.1 Company Overview
5 Shoulder Replacement Market Pipeline Products
6 Financial Deals Landscape
6.1 Acquisition
6.1.1 Olympus to Sell Olympus Terumo Biomaterials and FH Orthopedics
7 Recent Developments
7.1 Financial Announcements
7.1.1 Dec 20, 2023: Significant Health & Quality of Life Improvements Achieved in Children with Achondroplasia Treated for One Year with TransCon CNP at 100 µg/kg/week